Ornaghi, Carmine (2009) Mergers and innovation in big pharma. International Journal of Industrial Organization, 27 (1), 70-79. (doi:10.1016/j.ijindorg.2008.04.003).
Abstract
The aims of this paper are to study the effects of mergers on the R&D activity of consolidated firms and to explore the relationship between ex-ante relatedness of merging parties and their ex-post performances. The analysis is conducted using data of the pharmaceutical industry for the period 1988–2004. The empirical results suggest that merged companies have on average, worse performances than the group of non-merging firms.
This result is confirmed when I account for the endogeneous formation of mergers by selecting a control group first using the propensity score method and then taking into account the technological relatedness of the firms. Finally, I find that higher levels of technological relatedness are not associated with better R&D outcomes
This record has no associated files available for download.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.